1. Expert consensus statement on the diagnosis and treatment of fulminant myocarditis in the context of the COVID-19 pandemic
   O. Sh. Oynotkinova et al, 2020, Academy of medicine and sports CrossRef
2. Effect of Acute Immunosuppression on Left Ventricular Recovery and Mortality in Fulminant Viral Myocarditis: A Case Series and Review of Literature
   Pierre Yves Turgeon et al, 2021, CJC Open CrossRef
3. Treatments of Fulminant Myocarditis in Acute Phase
   Jiangang Jiang et al, 2022, Fulminant Myocarditis CrossRef
4. Diagnosis and Management of Myocarditis: An Evidence-Based Review for the Emergency Medicine Clinician
   Michael Gottlieb et al, 2021, The Journal of Emergency Medicine CrossRef
5. In-hospital and post-discharge outcomes of pediatric acute myocarditis underwent after high-dose steroid or intravenous immunoglobulin therapy
   Ming-Shyan Lin et al, 2019, BMC Cardiovascular Disorders CrossRef
6. Intravenous Immunoglobulin Therapy for Acute Myocarditis in Children and Adults
   Xin Huang et al, 2019, International Heart Journal CrossRef
7. Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis
   null null et al, 2019, Science China Life Sciences CrossRef
8. Influenza Myopericarditis and Pericarditis: A Literature Review
   Milan Radovanovic et al, 2022, Journal of Clinical Medicine CrossRef
9. Fulminant Myocarditis: Epidemiology, Pathogenesis, Diagnosis, and Management
   Ajay Nair Sharma et al, 2019, The American Journal of Cardiology CrossRef
10. Fulminant but Not Fatal
    Theresa N. Duong et al, 2016, The American Journal of Medicine CrossRef
11. An Overview of Acute Flaccid Myelitis
    Aseem Setia et al, 2022, CNS & Neurological Disorders - Drug Targets CrossRef
12. Intravenous immunoglobulin in children with acute myocarditis and/or early dilated cardiomyopathy
    Amarendra N. Prasad et al, 2014, Indian Pediatrics CrossRef
13. T‐cell immunity in myocardial inflammation: pathogenic role and therapeutic manipulation
    E Stephenson et al, 2017, British Journal of Pharmacology CrossRef
14. Understanding long COVID myocarditis: A comprehensive review
    Arti Srivastava et al, 2024, Cytokine CrossRef
15. Effect of Intravenous Immunoglobulin for Fulminant Myocarditis on In-Hospital Mortality: Propensity Score Analyses
    Toshiaki Isogai et al, 2015, Journal of Cardiac Failure CrossRef
16. MicroRNA‐377 exerts a potent suppressive role in osteosarcoma through the involvement of the histone acetyltransferase 1‐mediated Wnt axis
    Peng Xia et al, 2019, Journal of Cellular Physiology CrossRef
17. Assessment of Intravenous Immunoglobulin Indications in Pediatric Intensive Care
    Ferhat Sarı et al, 2022, Journal of Dr Behcet Uz Children s Hospital CrossRef
18. Follow-Up and Long-Term Prognosis of Myocarditis and Fulminant Myocarditis
    Jiangang Jiang et al, 2022, Fulminant Myocarditis CrossRef
19. Successful treatment of fulminant myocarditis with intra-aortic balloon pump counterpulsation combined with immunoglobulin and glucocorticoid in a young male adult
    Huanhuan Li et al, 2022, Frontiers in Cardiovascular Medicine CrossRef